Celldex Therapeutics Inc

NASDAQ: CLDX
$37.02
-$0.75 (-2.0%)
Closing price April 24, 2024
Celldex Therapeutics Inc is a pioneering biopharmaceutical firm focused on crafting innovative antibody-based treatments for inflammatory, allergic, autoimmune, and other severe diseases. With a notable drug candidate, CDX-0159, currently in Phase II trials targeting the KIT receptor tyrosine kinase, Celldex is at the forefront of addressing unmet medical needs. Founded in 1983 and based in Hampton, New Jersey, the company also benefits from strategic research partnerships, including one with Yale University, to advance its mission of developing life-changing therapeutics.

Monday's Top Analyst Upgrades and Downgrades: American Express, Capital One, Levi Strauss, Pinterest, Peloton, Synchrony, T-Mobile and More
Monday’s top analyst upgrades and downgrades included American Express, Capital One, Levi Strauss, Pinterest, Peloton, Synchrony and T-Mobile.
Chris Lange
Published:

Major 2019 Biopharma Catalysts Coming in February and March
Here, 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and U.S. Food and Drug Administration (FDA) updates in February and March.
Chris Lange
Published:
Last Updated:

Ambev, Renren Slide into Friday's 52-Week Low Club
Ambev, Renren, Celldex, and Yatra Online all posted new 52-week lows Friday.
Paul Ausick
Published:
Last Updated:

General Electric, Starbucks Drop into Thursday's 52-Week Low Club
General Electric, Starbucks, General Dynamics, and Celldex all posted new 52-week lows Thursday.
Paul Ausick
Published:
Last Updated:

Oracle, Starbucks Plunge into Wednesday's 52-Week Low Club
Oracle, Starbucks, Helios and Matheson, and Celldex all posted new 52-week lows Wednesday.
Paul Ausick
Published:
Last Updated:

Gogo, Tesaro Drop into Wednesday's 52-Week Low Club
Banco Bradesco, Gogo, Tesaro, and Celldex all posted new 52-week lows Wednesday.
Paul Ausick
Published:
Last Updated:

JC Penney, Spectra Energy Slip into Tuesday's 52-Week Low Club
J.C. Penney, Helios and Matheson, Celldex, and Spectra Energy Partners all posted new 52-week lows Tuesday.
Paul Ausick
Published:
Last Updated:

MGIC, Juniper Networks Slide into Wednesday's 52-Week Low Club
MGIC Investment Group, Celldex Therapeutics, Juniper Networks, and Healthcare Services Group all posted new 52-week lows on Wednesday.
Paul Ausick
Published:
Last Updated:

Celldex, Acacia Plummet into Monday's 52-Week Low Club
Celldex Therapeutics, Acacia Communications, Apricus Biosciences, and Ctrp.com all posted new 52-week lows Monday.
Paul Ausick
Published:
Last Updated:

Why Celldex Therapeutics Is Getting Crushed
Celldex Therapeutics shares were absolutely crushed on Monday morning after the firm announced results to its midstage breast cancer study.
Chris Lange
Published:
Last Updated:

30 Big Biotech Events Coming in 2018
Jefferies has compiled a list of over 30 biotech events taking place in 2018 that could result in significant stock moves. Some stocks have the potential to double or even crater, should a study be...
Chris Lange
Published:
Last Updated:

Top Analyst Upgrades and Downgrades: American Airlines, Boeing, Cabot Oil & Gas, Pandora, Southern Co., Vertex and Many More
The top analyst upgrades, downgrades and other research calls include American Airlines, Boeing, Cabot Oil & Gas, Pandora Media, Southern Co. and Vertex Pharmaceuticals.
Jon C. Ogg
Published:
Last Updated:

Macy's, Tegna Drop into Tuesday's 52-Week Low Club
Macy's, Tegna, Celldex, and DryShips posted new 52-week lows Tuesday.
Paul Ausick
Published:
Last Updated:

Celldex Therapeutics Sinks Following ASCO Results
Celldex Therapeutics was another big mover coming out of the Annual Meeting for the American Society of Clinical Oncology (ASCO). Unfortunately, the move was to the downside.
Chris Lange
Published:
Last Updated:

Key FDA Decisions and Trial Results Expected in October
24/7 Wall St. has collected several big FDA decisions and mid-stage to late-stage trials that should be announced in October.
Chris Lange
Published:
Last Updated: